This story is from the CurrentWire archive. Coverage details reflect the last time it was updated.
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
CEO Michael Halstead to participate in a fireside chat on Monday, September 14, 2026 at 9:00 a.m. EDT NEW YORK and TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) — Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), […]
Financial Post
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Financial Post.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
From the CurrentWire archive
- Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Orion Digital to Participate in H.C. Wainwright’s 28th Annual Global Investment Conference
- Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Financial Post (financialpost.com), a Tier B publisher, filed this report on . CurrentWire published this page 1 minute later, on .
Filed under Business · US & Canada · Press release. Topics extracted from this report, with other live CurrentWire stories mentioning each: Toronto (8), New York (26), Annual Global Investment Conference (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.